Top losers include Milestone Pharmaceuticals Inc., Wolfspeed, Inc., and Direct Digital Holdings, Inc.
From Financial Modeling Prep: 2025-03-28 14:00:00 Milestone Pharmaceuticals Inc. (NASDAQ:MIST) stock price plummeted by 59.56% after FDA’s rejection of its
